• Bhubaneswar India
  • Contact+ 91-9938772605
  • Mon - Sat : 10:00AM - 6:00PM

Tag: medications

news

New in Samsung Health: Medication Tracking Now Available in India

Oct 28, 2024 by Sujata 0 Comments #medications, #Tracking

Bengaluru, October 28, 2024 – India’s largest consumer electronics brand, Samsung announced that it has added the Medications tracking feature1 to the Samsung Health app2 to help users manage their health more comprehensively.

The feature will not only allow users to keep track of their prescribed or over-the-counter medication regime but will also offer important medical information and tips. The feature can help in tracking medication adherence consistency for those, who are on a medication journey for hypertension, diabetes, PCOS, PCOD and other chronic diseases that require timely doses.

“Samsung is a brand that puts its customers first and continuously works on products and services to improve their daily lives. We aim to build a holistic health platform for people to understand and manage their health better by connecting devices and services. With the addition of Medications feature for India in the Samsung Health app, we believe users will be able to manage their medications more conveniently, improve adherence, and ultimately maintain better health,” said Kyungyun Roo, Managing Director, Samsung Research Institute, Noida.

The Medications feature, the result of a collaborative effort between R&D, Design and Consumer Experience teams at Samsung, has been designed keeping in mind the needs of Indian consumers. Upon entering the name of a select medication into the Samsung Health app, the Medications feature will provide users with detailed information including general descriptions, as well as its possible side effects.

In addition, the new feature will provide information on adverse reactions from drug-to-drug interactions and other relevant safety guidance. Users can set up alerts to remind them both when to take their medications and when to refill them seamlessly through the Samsung Health App.

These alerts can be fine-tuned to the need of the individual user, so the medications can be prioritized depending on their importance to the user, with Samsung Health sending reminders ranging from “gentle” to “strong”. Galaxy Watch users will also receive reminders right on their wrist so they can stay on top of their medication schedules, even when away from their phones.

The Samsung Health app already provides a range of advanced health offerings spanning sleep management3, mindfulness programmes and irregular heart rhythm notification capabilities. The introduction of the Medication tracking feature in India will further reinforce Samsung’s commitment to create holistic wellness experiences for its users, enabling them to lead healthier, more fulfilling lives.

The Medications tracking feature will be available on the Samsung Health app in India via the app updates.

Samsung Health Medications feature is intended to help users manage their medication list and schedule. Information provided is evidence-based content licensed from Tata 1mg.

Requires smartphone with Android 10.0 or later and Samsung Health app version 6.28 or later. Availability for the features may vary by device.

Sleep features are intended for general wellness and fitness purposes only. The measurements are for your personal reference only. Please consult a medical professional for advice.

The IHRN feature is only available in select markets. Available on Wear OS devices version 4.0 or later. It is not intended to provide a notification on every episode of irregular rhythm suggestive of AFib and the absence of a notification is not intended to indicate no disease process is present. It is not intended for users with other known arrhythmias. The features are supported via the Samsung Health Monitor app. Availability may vary by market or device. Due to market restrictions in obtaining approval/registration as a Software as a Medical Device (SaMD), it only works on watches and smartphones purchased in the markets where service is currently available (however, service may be restricted when users travel to non-service markets). This app can only be used for measuring in ages 22 and over.

Advanced medications to quickly cure Avascular Necrosis without surgery
health

Advanced medications to quickly cure Avascular Necrosis without surgery

Jun 15, 2022 by Praveen 0 Comments #Avascular Necrosis, #medications

Of the string of maladies that can afflict COVID recovering patients, whilst Black Fungus has been rightly feared. During this long COVID, the possibility of AVN of the hip can be conclusively established by a MRI scan, and successfully treated with bisphosphonates.

With around 3 decades of excellence in treating Avascular Necrosis (AVN), Dr Sanjay Agarwala, has revolutionized the treatment modality for such cases with his latest findings. While most of the patients were being recommended for surgical procedure, Dr Agarwala has been successfully treating it with bisphosphonates.

According to his study and findings, with the use of bisphosphonates, patients in stage 1 had consistently a success rate of 97%, while stage 2 had 93% and stage 3 had 70% success rate, which is certainly better than the off-chance of a possible 50 % success after surgery. Starting from 2001 , different aspects and findings were published in international peer-reviewed Rheumatology , Orthopaedic and Arthroplasty journals. This established the place of the successful management of this condition medically, not only for the hips, but also for the vexing condition in other bones.

This condition can be then controlled, treated, reversed and if picked up early , cured by this treatment methodology described by Dr Agarwala over 20 years in peer reviewed international scientific journals, the latest being in the BMJ case reports this last weekend.

AVN has traditionally had a plethora of surgical procedures, attesting to the fact that no single successful procedure had stood the test of time. Most procedures only seemed to work in the hands of the originators, and literature would suggest at best 50 % good results. 22 years ago, a young gentleman reached me with diagnosis of AVN of the hip, after being recommended for a surgery by multiple senior orthopaedic surgeons. Recognising the reluctance of this patient, and considering that the local affected hip bone would be softened due to the interrupted blood supply, a truly revolutionary treatment was performed, and even after 22 years the patient has a normal cured existence.

Dr Sanjay Agarwala then went on to describe the possibility of the use of these group of drugs , normally used for the correction of osteoporosis ( softening of bones ) for this particular localised bone softening condition. Such revolutionary drugs have been highly beneficial in quick cure for conditions like spontaneous osteonecrosis of the knee (SPONK / SONK ), Transient osteoporosis of the hip and bone edema also.

Leukaemia survivors, as young as 15 years of age, with proper treatment, would overcome their disease, but sometimes suffer from debilitating AVN.

Dr Banavali from Tata Cancer hospital, had a cohort of these unfortunate cases. Collaborating with Dr Agarwala and using this regimen, the two doctors published their astonishing work in the global journal of oncology. Their patient Rahul Dhinde, a rustic young child then, had tears of joy when he confirmed that once treated for AVN, he could run and play as an equal with his older brother! A strapping young man now he is delighted to confirm this successful story from his village.

Since the press picked up the story of AVN of the hips from the recent BMJ case-report publication, numerous orthopaedic consultants from all over India, have corroborated Dr Agarwala’s findings.